Missense and
protein-truncating mutations of the human
potassium-chloride co-transporter 3 gene (KCC3) cause
hereditary motor and sensory neuropathy with agenesis of the corpus callosum (
HMSN/ACC), which is a severe
neurodegenerative disease characterized by axonal dysfunction and neurodevelopmental defects. We previously reported that KCC3-truncating mutations disrupt brain-type
creatine kinase-dependent activation of the
co-transporter through the loss of its last 140
amino acids. Here, we report a novel and more distal
HMSN/ACC-truncating mutation (3402C → T; R1134X) that eliminates only the last 17 residues of the
protein. This small truncation disrupts the interaction with brain-type
creatine kinase in mammalian cells but also affects plasma membrane localization of the mutant transporter. Although it is not truncated, the previously reported
HMSN/ACC-causing 619C → T (R207C) missense mutation also leads to KCC3 loss of function in Xenopus oocyte flux assay. Immunodetection in Xenopus oocytes and in mammalian cultured cells revealed a decreased amount of R207C at the plasma membrane, with significant retention of the
mutant proteins in the endoplasmic reticulum. In mammalian cells,
curcumin partially corrected these
mutant protein mislocalizations, with more
protein reaching the plasma membrane. These findings suggest that mis-trafficking of
mutant protein is an important pathophysiological feature of
HMSN/ACC causative KCC3 mutations.